Yearly Archives: 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/059 Tier 2 – medium impact Date of issue: 23rd May 2024 There will be intermittent supplies of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules for the foreseeable future. Unlicensed supplies of salbutamol 2.5mg [...]

The post Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/05/2024) confirmed the following initial list of price concessions for May 2024. This announcement comes late in the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC [...]

The post DHSC’s May 2024 Price Concessions – 1st Update appeared first on Community Pharmacy England.

Community Pharmacy England has issued the following statement in response to the Prime Minister’s announcement of a UK General Election. Our Chief Executive Janet Morrison said: “We have been preparing for the news of a UK General Election for many months, briefing and building support for community pharmacy across all political parties. That work remains [...]

The post UK General Election announced appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) Drug alert number: EL (24)A/17 Date issued: 22 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS [...]

The post MHRA Class 4 Medicines Notification: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions (SSP053 and SSP054). SSP053 and SSP054 were due to expire on 21 June but the end date has been further extended to Friday 19 July 2024. In response to a [...]

The post Two Clarithromycin SSPs extended appeared first on Community Pharmacy England.